₹42.00
−0.24%NSE close, 16 Nov 2026
−35.43%
ZENITH DRUGS is a small cap company, listed on NSE SME under the symbol ZENITHDRUG. At ₹42.00 a share, the market values the whole company at ₹72 crore. NSE SME is the exchange's platform for small and medium companies, which report their results every half year.
In FY26, it reported sales of ₹171 crore and a net profit of ₹4 crore, an operating margin of 7.1%.
The market values the company at 17.0 times its profit over the last twelve months and 0.95 times its book value; its return on equity is 5.6% and its borrowings are 0.83 times its equity.
Promoters hold 69.98% of the shares. Foreign institutions hold 0.00%, and domestic institutions, mutual funds among them, 0.00%.
Over the past year the share price has fallen 32.3%, and it is 34.0% below its 52-week high.
Listed on NSE SME, the platform for small and medium companies: its shares trade in large lots and often thinly, so the price can move sharply on a few trades, and companies file results every half year.
₹ crore. Consolidated figures where the company filed them, standalone otherwise (marked S).
| Line | 6M to Mar 2024 | Sep 2024 S | 6M to Mar 2025 S | 6M to Sep 2025 S | 6M to Mar 2026 S | 6M to Sep 2026 S |
|---|---|---|---|---|---|---|
| Sales | 62.2 | 67.7 | 65.6 | 78.2 |
The financial results for the period ended September 30, 2026.
The financial results for the period ended September 30, 2026.
Securing a tender awarded Rajasthan Medical Services Corporation Limited.
Securing a tender awarded by Uttar Pradesh Medical Supplies Corporation Limited.
Outcome of Board Meeting held on October 13, 2026.
| 81.5 |
| Expenses | 56.4 | 60.9 | 58.8 | 72.1 | 87.0 | 75.9 |
|---|
| Operating profit | 5.8 | 6.8 | 6.8 | 6.2 | 6.0 | 5.6 |
|---|
| Operating margin | 9.4% | 10.0% | 10.4% | 7.9% | 6.4% | 6.8% |
|---|
| Other income | 2.1 | 0.9 | 1.7 | 1.9 | 3.2 | 2.8 |
|---|
| Interest | 1.6 | 1.2 | 2.5 | 2.5 | 3.1 | 3.1 |
|---|
| Depreciation | 0.7 | 0.7 | 2.3 | 3.0 | 3.1 | 2.6 |
|---|
| Profit before tax | 5.8 | 5.7 | 3.5 | 2.3 | 3.1 | 2.6 |
|---|
| Tax | 1.9 | 0 | 2.1 | 0 | 1.4 | 0 |
|---|
| Net profit | 3.9 | 5.7 | 1.4 | 2.3 | 1.6 | 2.6 |
|---|
| EPS (₹) | 3.60 | 3.33 | 0.84 | 1.36 | 0.94 | 1.53 |
|---|
₹ crore, financial years to March.
| Line | FY24 | FY25 S | FY26 S |
|---|---|---|---|
| Sales | 132 | 133 | 171 |
| Expenses | 115 | 120 | 159 |
| Operating profit | 16.9 | 13.6 | 12.2 |
| Operating margin | 12.9% | 10.2% | 7.1% |
| Other income | 2.1 | 2.6 | 5.1 |
| Interest | 3.0 | 3.7 | 5.6 |
| Depreciation | 1.3 | 3.0 | 6.1 |
| Profit before tax | 13.4 | 9.3 | 5.4 |
| Tax | 3.8 | 2.1 | 1.4 |
| Net profit | 9.6 | 7.2 | 3.9 |
| EPS (₹) | 6.91 | 4.18 | 2.30 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY24 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | −13.0 | −5.5 | 8.9 | −4.1 |
| From investing | −9.0 | −31.4 | −13.7 | −1.4 |
| From financing | 30.5 | 28.4 | 4.8 | 5.7 |
| Spent on fixed assets | – | 0 | −9.7 | −0.3 |
| Free cash flow | – | −5.5 | −0.8 | −4.4 |
Margins, returns, debt, tax and cash.
| Line | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net margin | 7.3% | 5.4% | 2.3% |
| Operating margin | 12.9% | 10.2% | 7.1% |
| Return on equity | – | 10.3% | 5.4% |
| Return on capital employed | – | 11.0% | 8.6% |
| Return on assets | – | 4.4% | 2.1% |
| Debt to equity | – | 0.70 | 0.75 |
| Interest coverage | 5.50 | 3.50 | 2.00 |
| Debt to assets | – | 0.30 | 0.29 |
| Current ratio | – | 1.45 | 1.37 |
| Quick ratio | – | 0.95 | 0.92 |
| Cash ratio | – | 0.00 | 0.00 |
| Asset turnover | – | 0.83 | 0.91 |
| Fixed asset turnover | – | 3.33 | 4.62 |
| Inventory turnover | – | 2.20 | 2.90 |
| Receivables turnover | – | 2.20 | 2.30 |
| Gross margin | – | 34.4% | 28.4% |
| Cash from operations to profit | -136.0% | -76.0% | 225.0% |
| Effective tax rate | 28.3% | 22.7% | 26.7% |
Securing a tender awarded by Haryana Medical Services Corporation Limited.
A copy Srutinizers report of Annual General Meeting held on September 29, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of Annual General Meeting held on September 29, 2026
Notice of Annual General Meeting to be held on September 29, 2026
Outcome of Board Meeting held on September 05, 2026.
Allotment of 1609050 share warrants pursuant to Preferential Issue at its meeting held on August 26, 2026
Outcome of Board Meeting held on August 26, 2026.
Outcome of Board Meeting held on August 26, 2026.
A copy Srutinizers report of Extraordinary General Meeting held on July 23, 2026. Further, the company has informed the Exchange regarding voting results.